PTC Therapeutics Inc (PTCT) — Capital Reinvestment Ratio
PTC Therapeutics Inc (PTCT) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow ($870.10 Million) in capital expenditures ($2.53 Million). Check PTC Therapeutics Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
PTC Therapeutics Inc Capital Reinvestment Ratio (2025–2025)
This chart tracks PTC Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see PTC Therapeutics Inc operating cash flow efficiency.
Annual Capital Reinvestment Ratio for PTC Therapeutics Inc (2025–2025)
Year-by-year Capital Reinvestment Ratio for PTC Therapeutics Inc from 2025 to 2025. See PTC Therapeutics Inc (PTCT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $711.20 Million | $8.86 Million | — |